Amplification was found to be the most prevalent alteration type for SERPINC1 and PLAT, with high amplification frequencies notably observed in UCS, liver hepatocellular carcinoma (LIHC), CHOL, and breast invasive carcinoma (BRCA). Here, SERPINC1 is linked to invasive breast carcinoma.